Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The Center for Cancer Research (CCR) of the NCI is one of the largest centers for cancer research in the world, with over 200 Principal Investigators, and has a major role in development and implementation of many of new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics.
The Translational Research in Clinical Oncology (TRACO) course is usually held on Monday afternoons from September to November 2020 by WebEx. TRACO is designed to provide an overview of general principles of cancer biology and treatment, epidemiology, genomics, precision medicine, mechanisms of resistance, use of preclinical models, and identification of novel molecular targets. Participants will have an unprecedented opportunity to learn new information, glimpse into future developments of translational research in clinical oncology and meet leaders in cancer research. The participation of NIH Postdoctoral and Clinical Fellows is encouraged. For schedule details, please visit the TRACO program website.
Registration closes September 8th, 2020.